Status:
COMPLETED
Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)
Lead Sponsor:
Janssen Research & Development, LLC
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Brief Summary
The purpose of this study is to assess the treatment patterns in participants with metastatic castration-resistant prostate cancer (mCRPC). Additionally, participant's demographic and clinical charact...
Detailed Description
This is an observational (study in which participants identified as belonging to study groups are assessed for biomedical or health outcomes), longitudinal (correlational research study that involves ...
Eligibility Criteria
Inclusion
- Histologically or cytologically confirmed adenocarcinoma of the prostate
- Report of previous surgical or medical castration
- Castration-resistant prostate cancer (CRPC) diagnosis in or before 2009
- Metastatic disease documented by positive bone scan or metastatic lesions on computed tomography or magnetic resonance imaging in or before 2009. If lymph node metastasis is the only evidence of metastasis, it must be 2 centimeters (cm) in diameter
Exclusion
- Participation in any investigational drug or device study or early access programme
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
382 Patients enrolled
Trial Details
Trial ID
NCT02230059
Start Date
July 1 2013
End Date
May 1 2014
Last Update
September 25 2014
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Brasília, Brazil
2
Curitiba, Brazil
3
Distrito Federal, Brazil
4
Florianópolis, Brazil